Leading science, pioneering therapies
CRM Publications

IL-10-producing, ST2-expressing Foxp3(+) T cells in multiple sclerosis brain lesions.

TitleIL-10-producing, ST2-expressing Foxp3(+) T cells in multiple sclerosis brain lesions.
Publication TypeJournal Article
Year of Publication2017
AuthorsZandee SElizabeth, O'Connor RAnthony, Mair I, Leech MDawn, Williams AC, Anderton SMark
JournalImmunol Cell Biol
Date Published2017 Feb 07
ISSN1440-1711
Abstract

CD4(+)Foxp3(+) T regulatory (Treg) cells provide a key defence against inflammatory disease, but also have an ability to produce pro-inflammatory cytokines. The evidence for these two possibilities in multiple sclerosis (MS) is controversial. However, this has largely been based on studies of circulating Treg cells derived from peripheral blood, rather than the central nervous system. We show that Foxp3(+) cells in the brains of MS patients predominantly produce interleukin-10 (IL-10) and show high expression of the IL-33 receptor ST2 (associated with potent Treg function), indicating that Treg in the inflamed brain maintain their suppressive function.Immunology and Cell Biology advance online publication, 7 February 2017; doi:10.1038/icb.2017.3.

DOI10.1038/icb.2017.3
Alternate JournalImmunol. Cell Biol.
PubMed ID28169287
Publication institute
CRM